In 2023 Cullgen completed a Series C financing led by AstraZeneca-CICC Venture Capital Partnership, and also announced a strategic partnership with Astellas Pharma Inc. About the Proposed Transaction ...

"AstraZeneca plans major $3.5bn expansion drive in the US" was originally created and published by Investment Monitor, a ...

Eric Le Berrigaud, an analyst from Stifel Nicolaus, reiterated the Buy rating on AstraZeneca (AZN – Research Report). The associated price target remains the same with p14,100.00. Eric Le Berrigaud ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy ... I mean, we are building this new site in Kendall Square in Boston because it's an important location for ...

After hitting record highs following Trump’s victory, the Dow and S&P 500 hit the brakes on Tuesday, a day before the release ...

The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...

The boosted U.S. investment is said to be a response to Donald Trump’s election win, and leaves in doubt the pharmaceutical ...

(Reuters) – Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time in less than four months on ...

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...

UK-listed drugmaker AstraZeneca lifted its full-year sales and profit guidance, on the back of strong sales and revenue ...

AstraZeneca Expands U.S. Investment Plan The boosted U.S. investment is said to be a response to Donald Trump's election win, and leaves in doubt the pharmaceutical company's plans to invest in a ...